SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-012258
Filing Date
2022-03-29
Accepted
2022-03-29 17:29:44
Documents
101
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vtvt-10k_20211231.htm   iXBRL 10-K 3344314
2 EX-4.3 vtvt-ex43_11.htm EX-4.3 20894
3 EX-21.1 vtvt-ex211_12.htm EX-21.1 2946
4 EX-23.1 vtvt-ex231_7.htm EX-23.1 10953
5 EX-31.1 vtvt-ex311_6.htm EX-31.1 17698
6 EX-31.2 vtvt-ex312_9.htm EX-31.2 17767
7 EX-32.1 vtvt-ex321_10.htm EX-32.1 7500
8 EX-32.2 vtvt-ex322_8.htm EX-32.2 7352
9 GRAPHIC gnzf2mtk5vqu000002.jpg GRAPHIC 44675
10 GRAPHIC gnzf2mtk5vqu000001.jpg GRAPHIC 44675
  Complete submission text file 0001564590-22-012258.txt   12174875

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20211231.xsd EX-101.SCH 89069
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20211231_cal.xml EX-101.CAL 62231
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20211231_def.xml EX-101.DEF 346325
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20211231_lab.xml EX-101.LAB 615368
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20211231_pre.xml EX-101.PRE 493219
95 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-10k_20211231_htm.xml XML 2152564
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37524 | Film No.: 22782204
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences